BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3297754)

  • 1. Differential decrease in the rate of dopamine synthesis in several dopaminergic neurons of aged rat brain.
    Watanabe H
    Exp Gerontol; 1987; 22(1):17-25. PubMed ID: 3297754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
    Barton AC; Moore KE; Demarest KT
    J Neural Transm; 1987; 68(1-2):25-39. PubMed ID: 2879883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of domperidone and haloperidol effects on different dopaminergic neurons in the rat brain.
    Farah JM; Demarest KT; Moore KE
    Life Sci; 1983 Oct; 33(16):1561-6. PubMed ID: 6633157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations.
    Kilts CD; Anderson CM; Ely TD; Nishita JK
    J Neurosci; 1987 Dec; 7(12):3961-75. PubMed ID: 3121804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of d-amphetamine, beta-phenylethylamine, cocaine and methylphenidate on the rate of dopamine synthesis in terminals of nigrostriatal and mesolimbic neurons and on the efflux of dopamine metabolites into cerebroventricular perfusates of rats.
    Nielsen JA; Chapin DS; Moore KE
    Life Sci; 1983 Nov; 33(19):1899-907. PubMed ID: 6645784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
    Estrella CR; Bregonzio C; Cabrera RJ
    Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrain differences of age-related changes in in vivo dopamine synthesis in the striatum and nucleus accumbens of the rat brain.
    Watanabe H
    J Pharmacobiodyn; 1987 Jul; 10(7):317-20. PubMed ID: 3694425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
    Yamada K; Demarest KT; Moore KE
    Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons between brain dopaminergic neurons of juvenile and aged rats: sex-related differences.
    Fernandez-Ruiz J; De Miguel R; Hernandez ML; Cebeira M; Ramos JA
    Mech Ageing Dev; 1992 Mar; 63(1):45-55. PubMed ID: 1351122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons.
    Gudelsky GA; Nwajei EE; Defife K; Nash JF
    Synapse; 1992 Dec; 12(4):304-11. PubMed ID: 1361248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of DN-1417, a thyrotropin releasing hormone analog, on dopaminergic neurons in rat brain.
    Nakahara T; Matsumoto T; Hirano M; Uchimura H; Yokoo H; Nakamura K; Ishibashi K; Hirano H
    Peptides; 1985; 6(6):1093-9. PubMed ID: 3938840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.
    Bardo MT; Bowling SL; Pierce RC
    Psychopharmacology (Berl); 1990; 101(3):338-43. PubMed ID: 2163539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat.
    Nishikawa T; Fage D; Scatton B
    Brain Res; 1986 May; 373(1-2):324-36. PubMed ID: 2424555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin interacts with dopaminergic neurons in rat brain.
    Reches A; Burke RE; Jiang D; Wagner HR; Fahn S
    Peptides; 1983; 4(1):43-8. PubMed ID: 6866808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
    Durham RA; Johnson JD; Moore KE; Lookingland KJ
    Brain Res; 1996 Sep; 732(1-2):113-20. PubMed ID: 8891275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.